# Opus Genetics (IRD) — Analyst Forecast

IRD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ird/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 18 | 0 | 0 | 18 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $8.00 | $13.57 | $20.00 | 7 |

Last price $4.05 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 6, 2026 | Jones Trading | Maintained | Buy | $17.00 |
| Oct 2, 2026 | Chardan Capital | Maintained | Buy | $16.00 |
| Sep 10, 2026 | Wedbush | Maintained | Outperform | $13.00 |
| Sep 9, 2026 | BTIG | Maintained | Buy | $12.00 |
| Sep 9, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Sep 9, 2026 | Oppenheimer | Maintained | Outperform | $20.00 |
| Sep 9, 2026 | Chardan Capital | Maintained | Buy | $16.00 |
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | $9.00 |
| Jul 29, 2026 | TD Cowen | Initiated Coverage | Buy | — |
| Jul 6, 2026 | BTIG | Maintained | Buy | $12.00 |
| Jul 6, 2026 | Chardan Capital | Maintained | Buy | $13.00 |
| Jun 18, 2026 | Chardan Capital | Maintained | Buy | $13.00 |
| Jun 17, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jun 16, 2026 | BTIG | Maintained | Buy | $12.00 |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | $11.00 |
| Jun 4, 2026 | Guggenheim | Initiated Coverage | Buy | $16.00 |
| May 21, 2026 | Leerink Partners | Initiated Coverage | Outperform | $10.00 |
| May 13, 2026 | Citizens | Maintained | Market Outperform | $11.00 |
| Apr 28, 2026 | Citizens | Initiated Coverage | Market Outperform | $12.00 |
| Mar 30, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | $15.00 |

## Frequently Asked Questions

### What is the price target for IRD stock?

The average 12-month analyst price target for Opus Genetics (IRD) is $13.57, with a high estimate of $20.00 and a low of $8.00, across 7 analysts.

### Is IRD a buy, sell, or hold?

Analysts covering Opus Genetics currently average a Buy rating: 18 buy, 0 hold and 0 sell, from 18 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for IRD?

The average price target of $13.57 implies 235.10% upside from the last price of $4.05.

### What is the latest analyst rating on IRD?

On Oct 6, 2026, Jones Trading maintained Opus Genetics at Buy with a price target of $17.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).